Jagsi, Reshma
Rivkees, Scott
Opipari, Valerie P.
Article History
Received: 26 March 2019
Accepted: 1 April 2019
First Online: 28 May 2019
Competing interests
: Reshma Jagsi has stock options as compensation for her advisory board role in Equity Quotient, a company that evaluates culture in health care companies; she has received personal fees from Amgen, Vizient, and grants for unrelated work from the National Institutes of Health, the Doris Duke Foundation, the Greenwall Foundation, the Komen Foundation, and Blue Cross Blue Shield of Michigan for the Michigan Radiation Oncology Quality Consortium. The remaining authors declare no competing interests.